Impact of core protein naturally selected mutants associated with HBeAg‐negative status in HBV biosynthesis

Abstract

AbstractHepatitis B e antigen (HBeAg) loss represents a late stage of chronic hepatitis B virus (HBV) infection associated with a drastic decrease in HBV‐DNA, a lower risk of disease progression, and the occurrence of several mutations in the preCore/core region. However, the underlying mechanisms supporting the downregulation of viral replication have yet to be elucidated. In the present study, the analysis of the frequency of subgenotype D1 core protein (HBc) mutations associated with HBeAg status revealed a higher mutation rate in HBeAg‐negative sequences compared to HBeAg‐positive ones. Particularly, 22 amino acids exhibited a higher frequency of mutation in HBeAg‐negative sequences, while the remaining residues showed a high degree of conservation. Subsequently, the assessment of HBc mutants derived from HBeAg‐negative patients in viral structure and replicative capacity revealed that HBc mutations have the ability to modulate the subcellular localization of the protein (either when the protein was expressed alone or in the context of viral replication), capsid assembly, and, depending on specific mutation patterns, alter covalently closed circular DNA (cccDNA) recycling and up‐ or downregulate viral replication. In conclusion, HBc mutations associated with HBeAg‐negative status impact on various stages of the HBV life cycle modulating viral replication during the HBeAg‐negative stage of infection.